SPP Polymer (SPPPOLY)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 1/1

Key Financials

Strengths

• Promoter holding of 67.08% demonstrates strong insider ownership and alignment with minority shareholders.
• Dividend yield of 3.46% indicates a commitment to returning cash even amid losses.
• ROCE of 7.02% is positive, showing some operational return above the cost of capital.
• Sales growth of -0.61% is nearly flat, providing revenue stability rather than a steep collapse.

Concerns

• Loss-making: profit growth of -182.76% and latest quarterly net profit of -₹1 Cr point to unsustainable earnings.
• Piotroski F-Score of 3/9 reflects weak financial health and a high likelihood of continuing distress.
• P/E of 0.00 with no book value or debt/equity data leaves investors blind on balance sheet risk.
• Packaging industry is competitive with limited pricing power, offering no obvious moat.

AI Analysis

At ₹13 and a ₹22 crore market cap, SPP Polymer is a microcap packaging company that fails many of my tests. A P/E of 0.00 tells me the market assigns no earnings; indeed, the latest quarter shows a ₹1 crore net loss on ₹54 crore sales, and profit growth has plunged 182.76%. This is not a business I can value with any margin of safety. Sales were nearly flat at -0.61%, so there is no secular decline, but also no momentum. Return on capital employed is just 7.02% – barely above a fixed deposit, and with no book value or debt/equity disclosure, I cannot assess balance sheet risk. The Piotroski F-Score of 3/9 screams financial distress. On the positive side, promoters hold 67.08%, so interests are aligned, and they still pay a 3.46% dividend – but that often masks cash outflows when earnings are negative. A 52-week range of ₹10.30 to ₹14.90 shows the stock is not speculative; it's a quiet, ignored business. In the packaging industry, without pricing power or scale, moats are rare. I see no durable competitive advantage here. This looks like a potential turnaround only if management can cut costs and return to profitability. But Graham would demand clear evidence of improvement, not hope. For now, the figures fail my safety criteria. I'd rather watch from the sidelines, waiting for either a deeply discounted asset play or proven earnings recovery. At best, it's a show-me story.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer